Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6109965 | Journal of Hepatology | 2009 | 9 Pages |
Abstract
Normoglycemia alone cannot prevent hepatic steatosis and glycogen accumulation or the development of HCAs in GSD-Ib, providing one explanation why GSD-Ib patients maintaining normoglycemia under intense dietary therapy continue at risk for this long-term complication.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Wai Han Yiu, Chi-Jiunn Pan, Paul A. Mead, Matthew F. Starost, Brian C. Mansfield, Janice Y. Chou,